← Back to contracts

DoW Ovarian Cancer, Clinical Trial Award

US Dept › of the Army -- U › S › Army Medical Research Acquisition Activity (USAMRAA) grant open #HT942526OCRPCTA
Response due Oct 01, 2026 · 00:00 UTC

Summary

The Department of the Army (USAMRAA) is soliciting applications for the Department of Defense (DoD) Ovarian Cancer Research Program (OCRP) Clinical Trial Award. This federal grant opportunity supports clinical trial research related to ovarian cancer. The award is administered through the U.S. Army Medical Research Acquisition Activity (USAMRAA). Full programmatic details, eligibility requirements, and funding levels are not specified in the synopsis text provided.

How they evaluate

Submission: Grants.gov federal grants portal (electronic submission)

Risks & flags

  • Synopsis contains minimal detail — no funding amount, no scope of work, no eligibility criteria, and no programmatic requirements are disclosed; full program announcement must be reviewed before drawing further conclusions.
  • Very long open window (05/04/2026 – 10/01/2026) is consistent with a broad program announcement but limits competitive intelligence at this stage.

Market context

inferred from NAICS
Professional, Scientific & Technical Services
NAICS 541711
US market size
$2.0T
Typical award
$25K – $50M
Typical buyers
All federal civilianDoDStates
Commonly required
8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

DoW Ovarian Cancer, Clinical Trial Award
Due Oct 01
Onboard